Kelly Saluti

Senior Director Clinical Operations at Stoke Therapeutics

Kelly Saluti has a diverse work experience spanning over several pharmaceutical and medical device companies. Kelly currently serves as the Director of Clinical Operations at Stoke Therapeutics, where they lead and oversees the clinical operations strategy for a rare disease program. In this role, they are responsible for ensuring the successful delivery of trials within time, quality, and budget, while also mentoring junior staff and implementing operational processes and standards.

Prior to joining Stoke Therapeutics, Kelly worked at Vertex Pharmaceuticals for ten years, where they held several positions, including Director of Program and Clinical Trial Management, Associate Director of Program Operations Management, and Senior Clinical Project Manager. Kelly was responsible for overseeing program and trial management, as well as driving all aspects of trial planning, execution, and reporting.

Before Vertex Pharmaceuticals, Kelly worked at EMD Serono, Inc. as a Senior Clinical Trial Manager, where they planned, implemented, and managed global clinical trials within agreed timelines and costs. Kelly also worked at Inverness Medical Innovations and Intercytex as a Senior Clinical Research Associate and Project Manager, respectively, where they managed multi-site clinical studies, developed company SOPs, and oversaw clinical sites and central IRBs.

Kelly's earlier experience includes working at Wyeth as a Clinical Trial Manager, where they oversaw the operational aspects of phase I-IV clinical studies, and at Organogenesis as a Clinical Research Associate, where they monitored class III devices for clinical trials.

Throughout their career, Kelly has demonstrated a strong ability to lead teams, drive study timelines, and ensure study quality and compliance with regulations. Kelly has a proven track record of successfully delivering trials and bringing value to clinical operations programs.

Kelly Saluti attended Saint Anselm College from 1995 to 1999, where they earned a Bachelor of Arts (BA) degree in Biology.

Links

Previous companies

EMD Serono logo
Organogenesis logo
Vertex Pharmaceuticals logo

Timeline

  • Senior Director Clinical Operations

    February 1, 2024 - present

  • Director Clinical Operations

    May, 2022